ELECTROPHYSIOLOGY APPARATUS
20210220038 · 2021-07-22
Assignee
Inventors
Cpc classification
A61B2017/0019
HUMAN NECESSITIES
A61B2018/1467
HUMAN NECESSITIES
A61B18/1492
HUMAN NECESSITIES
International classification
A61B18/12
HUMAN NECESSITIES
Abstract
Treating patients with therapeutically effective electroporation requires the use of voltage potentials which when applied to the patient can be painful due to the noxious overstimulation of the afferent pain-receptive nerve fibres. An electrode assembly which includes electrodes for applying effective electroporation voltages, also comprises at least one electrode configured to apply a non-noxious, non-painful electrical stimulation which may be referred to as a “nerve block adjacent to the electroporation site.
Claims
1. An electrode assembly, for use in an electrophysiology apparatus comprising a high voltage pulsed DC supply, wherein, in use, the electrode assembly is connectable with the high voltage pulsed DC supply of the electrophysiology apparatus, and the assembly is configured to effect electroporation at tissue contributing to initiation and maintenance of atrial fibrillation and deliver nerve blocking stimulation, and wherein the electrode assembly comprises (i) at least one electroporation electrode configured to carry a current density sufficient to effect electroporation of tissue, and (ii) at least one other electrode configured to carry a current density that is insufficient to effect electroporation of tissue, characterised in that the at least one electroporation electrode and the at least one other electrode are configured to operate concomitantly and the at least one other electrode is configured to deliver nerve blocking stimulation by way of electrical pulses in the range 4000 Hz to 10,000 Hz.
2. An electrode assembly as claimed in claim 1 wherein the electrode assembly is configured to effect electroporation at ganglionated plexi in epicardial fat within the pericardial space.
3. An electrode assembly as claimed in claim 1, wherein the electrode assembly is configured as a tubular tip attachable to a catheter and bearing a plurality of electroporation electrodes configured to carry a current density sufficient to effect electroporation of tissue, and further electrodes configured to deliver nerve blocking stimulation by way of electrical pulses in the range 4000 Hz to 10,000 Hz.
4. An electrode assembly as claimed claim 1, comprising at least one high current density electrode and a corresponding dispersive electrode to be used in conjunction with the at least one high current density electrode, when connected to a direct current electrical supply for electroporation of tissue, optionally (a) wherein the electrode assembly comprises a monopolar electroporation electrode and a monopolar electrode configured to deliver nerve blocking stimulation by way of electrical pulses in the range 4000 Hz to 10,000 Hz or (b) wherein the electrode assembly comprises a monopolar electroporation electrode and a bipolar electrode configured to deliver nerve blocking stimulation by way of electrical pulses in the range 4000 Hz to 10,000 Hz.
5. An electrode assembly as claimed in claim 1, comprising at least a first pair of spaced apart corresponding electrodes for electroporation of tissue, and a further pair of corresponding electrodes juxtaposed to the first pair of spaced apart corresponding electrodes, at the periphery of the spacing between the first pair of electrodes to deliver nerve blocking stimulation by way of electrical pulses in the range 4000 Hz to 10,000 Hz, optionally wherein the electrode assembly comprises bipolar electroporation electrodes and a bipolar electrode configured to deliver nerve blocking stimulation by way of electrical pulses in the range 4000 Hz to 10,000 Hz.
6. An electrode assembly as claimed in claim 1, comprising a modular polygonal frame wherein a plurality of tubular parts are provided with a series of treatment electroporation electrodes, and the tubular parts are fixed together to form a polygonal frame with two parallel sides, and parallel tubular “bridging” elements are attached at opposite apexes to provide a 4×4 array of treatment electrodes characterised in that additional nerve blocking electrodes are located at each end of each of the series of electroporation electrodes.
7. An electrode assembly according to claim 1, wherein, in use, when the electrode assembly is connected with the high voltage pulsed DC supply of the electrophysiology apparatus to provide an assembly configured to effect electroporation of tissue and deliver nerve blocking stimulation the high voltage of the pulsed DC supply is about 1000 V, optionally wherein the nerve blocking stimulation is connectable to an AC supply.
8. A catheter apparatus comprising an electrode assembly of claim 1 wherein the catheter is configured to locate the electrode assembly at the heart.
9. A catheter apparatus of claim 8 wherein the catheter is configured to locate the electrode assembly at fat pads on the epicardial surface of the heart, such that in use, the electrode assembly selectively ablates ganglionated plexi whilst preserving the myocardium.
10. A catheter apparatus of claim 8 wherein the catheter comprises an inflatable balloon.
11. A catheter of claim 8 further comprising a high voltage pulsed DC supply of an electrophysiology apparatus.
12. A catheter of claim 8 wherein in use, the electrode assembly is connected with the high voltage pulsed DC supply of the electrophysiology apparatus to provide an assembly configured to effect electroporation of tissue and wherein electrophysiology apparatus provides an AC supply to provide a nerve blocking stimulation.
13. A catheter of claim 8 wherein in use, the electrode assembly is connected with the high voltage pulsed DC supply of an electrophysiology apparatus to provide an assembly configured to effect electroporation of tissue and wherein electrophysiology apparatus provides a DC supply to provide a nerve blocking stimulation.
14. A method for electroporation of the heart to treat atrial fibrillation comprising applying a plurality of electroporation electric pulses to a treatment volume of the heart, applying a plurality of nerve blocking pulses to a treatment volume of the heart concomitantly to the electroporation pulses.
15. A method for electroporation of a heart to treat atrial fibrillation as claimed in claim 14, wherein the applying steps are provided by an electrode assembly of claim 1 or a catheter of claim 8.
Description
[0037] The disclosed methods and apparatus will now be further described with reference to the accompanying drawings in which:
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049] Embodiments of different methods of electroporation of tissue will now be described as illustrative examples. While this is specifically described in relation to electroporation of heart tissue for stimulation for atrial fibrillation treatment, this technique could equally apply to any accessible target tissue structures in the body.
[0050] In one embodiment of the electrophysiology apparatus for electroporation with concomitant “nerve block” (
[0055] In a second embodiment of the electrophysiology apparatus for electroporation with concomitant “nerve block” the electrode assembly is configured for use in a procedure referred to here as use a “bi-polar” technique where the electrical energy flows between two electrodes for a localized approach. These electrodes are often the same size.
[0056] This technique has the following characteristics. [0057] The tissues treated are localized. [0058] The electrodes are often equal, or near equal size.
[0059] In the “bi-polar” technique two electrodes may be positioned at the tissue treatment site near, or adjacent to each other, and operated to effect electroporation of tissue.
[0060] This invention aims to modulate pain during the electroporation procedure to perhaps have the patient undergo only sedation.
[0061] Melzack R and Wall PD proposed the “Gate” theory of Pain in 1965 that is still (with some limitations) accepted as the way t brain and body experience pain, and ways of blocking, or modulating pain. (Science. 1965 Nov. 19; 150 (3699):971-9. “Pain mechanisms: a new theory.” Melzack R, Wall PD. Their theory suggested that pain is experienced in the brain and that the spinal cord carries signals to the brain, but the spinal cord is limited in respect of the numbers of signals that can be carried. It can almost be thought of as a ‘limited bandwidth” problem. The Gate Theory has been studied in detail, perhaps modified slightly, but continues to stand the test of time. (“The golden anniversary of Melzack and Wall's gate control theory of pain: Celebrating 50 years of pain research and management”, Katz J, Rosenbloom, Pain Res Manag. 2015 November-December; 20(6):285-6).
[0062] In addition, specific sine wave electrical stimulation for a “reversible nerve block” has been studied in detail to temporarily and reversibly block the action potential for peripheral nerves. The mechanism is either a depolarization, or “hyperpolarization” of the nerve fibres. The sinusoidal electrical stimulation at 4000 Hz to 10,000 Hz is thought to be ideal for this mechanism. Nearing and above 10,000 Hz, localized tissue heating becomes an issue resulting in pain, or even tissue damage.
[0063] In an embodiment, referring to
[0064] The greatest amount of pain will be experienced at the area treated by the smaller electroporation treatment electrode. Therefore, the nerve blocking electrical stimulation (4000 Hz-10,000 Hz) will be delivered adjacent to, or surrounding the treatment area where the smaller electroporation electrode 51 is positioned.
[0065] In an embodiment, referring to
[0066] Referring to
[0067] The electrodes “A”, “B”. “C”, and “D” can be independently active, or connected to one or more, or to all other electrodes. In a bi-polar arrangement, the current could flow from “A” to “B”, “A” to “C”, or “A” to “D”. There could be any permutation of the four electrodes.
[0068] Alternatively, all electrodes could be joined together inside the catheter, or the electroporation device itself with an inactive “dispersive” electrode.
[0069] Referring now to
[0070] Another form of electrode assembly is illustrated in
[0071] The electrode assembly of
[0072] It should be noted that the use of “monopolar and bipolar” is often used in the literature for describing the polarity of a waveform. This is not the case in this disclosure.
[0073] Referring to
[0074] A User Treatment menu allows a user to make a selection of various parameters and treatments.
[0075] The timing of delivered voltage is controlled internally through a microprocessor and software/firmware that enables the nerve stimulation to occur prior to the electroporation treatment and continue to complete at the same time, or the duration to be longer than the electroporation treatment.
[0076] All embodiments of the electrophysiology apparatus disclosed herein that is configured to effect electroporation of tissue comprises a high voltage pulsed DC supply, and may use at least one catheter including a catheter tip and electrode assembly connectable with the high voltage pulsed DC supply.
[0077] A suitable catheter may have an internal lumen (throughbore) for passage of electrical conductors or fluids.
[0078] The apparatus can be configured such that in use all of the electrodes on a single catheter tip have the same polarity and may be operated simultaneously. The apparatus may also be configured such that individual electrodes can be operated independently in order that voltage levels and polarity can be selectively controlled.
[0079] Electrodes may be designed to minimise sharp points or edges and preferably have smooth contours so that changes in surfaces, edges, ends or corners are rounded in order to reduce the risk of point concentration of the electric field.
[0080] An electrode for mounting upon a catheter tip may be of tubular form, and may be a short hollow cylinder having an outside diameter which may be from 2 to 4 mm but can lie in the range of from 1 mm up to 8 mm, and having a length of from 2 to 10 mm but can range from 0.5 mm up to 20 mm.
[0081] An electrode for mounting upon a catheter tip may be of tubular form and have one or more irrigation holes in the cylindrical sidewall allowing transmission of fluid supplied via the catheter to the external surface of the electrode. Such irrigation holes may be used to direct conductive saline towards target tissue, thereby increasing the distance over which the electric field will develop. Unlike conventional electrodes, such irrigation is not required for cooling of the electrode. Thus in alternative embodiments the irrigation hole(s), could be positioned in the surface of the catheter adjacent to the electrode, rather than being within the sidewall of the electrode.
[0082] Electrodes may be partially insulated to preferentially direct the electric field in a desired direction, and reduce the effect of the electric field in other directions.
[0083] Suitably, the electrode assembly may further comprise Insulation to keep electrical energy away from certain tissues or structures.
[0084] In embodiments, an expandable balloon may be use to provide the desired electrical insulation when appropriately positioned to cover parts of the electrode, leaving selected surface(s) exposed. Use of a balloon may also serve to move the electrode(s) closer to a tissue surface to be treated.
[0085] When a catheter tip is used to mount the electrode assembly the apparatus may comprise a sheath for electrical field blocking. The sheath is designed to prevent electrical fields from being absorbed by collateral structures near to the target tissue. The sheath may be configured to fit over the catheter tip and electrode assembly and may be fenestrated so as to have a plurality of openings for selective electric field emission. The openings serve as “windows” which may expose one or more electrodes to allow selective directional control for the electrical field emissions. The sheath may be adjusted circumferentially or longitudinally to influence electrical field emission.
[0086] The sheath may be fenestrated by provision of multiple holes or apertures positioned along the length and around the circumference of the sheath. It will be understood that rotational or axial movement of the sheath can provide for directing the field to different locations.
[0087] The sheath may comprise a metal reinforced polymer, such as a metal-braided polymer tubes of a type already widely used in the field for catheter structures. U.S. Pat. No. 6,635,047 B2, as an example, discloses a metal braid reinforced polymer tube for use as a coronary guide catheter. The parts of the tube containing the metal braid structure acts as a Faraday cage such that an electrical field does not pass through it.
[0088] The disclosed apparatus is useful for physiological modification of tissue, and can be operated by introduction of the electrode assembly to a surgical site, and control of an electrical power source to deliver powerful direct current pulses of short duration whereby a high voltage is applicable to tissue without the drawback of heat associated with electric current. This “electroporation” procedure modifies tissue such that the tissue is initially rendered more permeable and at increased energy levels (higher voltages and longer pulse durations) the electroporation can be controlled to cause cell death and thereby achieve an effect equivalent to tissue ablation.
[0089] Electroporation of target tissue is achievable using the apparatus disclosed herein, in that when electrodes of opposite charge are brought into contact with tissue a potential difference is applied across the tissue, and that electrode contact completes a circuit, which circuit includes the high voltage pulsed DC supply, electrodes and the tissue, and thereby accomplishes the electroporation of target tissue with no significant or enduring damage to tissue adjacent to the target tissue
[0090] Nerve blocking at about the same time, or otherwise synchronized with electroporation pulses during electroporation, is achievable using the apparatus disclosed herein, in that a high frequency (4000 Hz to 10,000 Hz) connected with selected electrodes such that certain ones of the electrodes provide nerve blocking stimuli. Nerve blocking may be timed by use of a controller such as a microprocessor, and software/firmware such that the nerve stimulation is initiated prior to the electroporation treatment, continues during the electroporation treatment, and either terminates at the same time as, or later than completion of the electroporation treatment.
[0091] Ganglionated plexi can be targeted by a localised electrical field generated around and between catheter tip and electrode assemblies as disclosed herein. Ganglionated plexi contain neurons which may be preferentially susceptible to electroporation in comparison to the myocardium. This susceptibility may be attributable to relative size difference between the two cell types; cardiac myocytes are typically 10-20 μm in diameter, and 50-100 μm in length whilst a neuron soma (body) can be from 4 to 100 μm in diameter, with the axons extending over 1000 μm in length. Control of the electrical field strength and extending the duration of pulses can shift the electroporation mechanism from reversible to irreversible electroporation. Taking account of the preferential susceptibility of neurons, appropriate control of electrical field strength and the duration of pulses applied to such differing cell types is found to result in selective irreversible electroporation of ganglionated plexi, with the adjacent cardiac myocytes being primarily reversibly electroporated.
[0092] It will be appreciated that the embodiments disclosed here indicative designs for the purposes of illustration and that other designs with different overall shape and electrode arrangements are possible, so that these examples are non-limiting and attention is directed to the scope of the claims hereinafter appearing.